NEULAND LABORATORIES
Back to Cashflow Statement
|
NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹347 Cr | ₹317 Cr | ₹261 Cr | ₹237 Cr | ₹60 Cr |
What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹347 Cr |
| Mar2025 | ₹317 Cr |
| Mar2024 | ₹261 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹60 Cr |
How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹347 Cr | 9.22 | |
| Mar2025 | ₹317 Cr | 21.53 | |
| Mar2024 | ₹261 Cr | 10.10 | |
| Mar2023 | ₹237 Cr | 292.81 | |
| Mar2022 | ₹60 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,245.9 Cr | -0.3% | 10.1% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -0.3% |
10.1% |
49.7% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses